Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05998096 · ClinicalTrials.gov registry record · NA

A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators

A NA study, sponsored by Lindenwood University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT05998096 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05998096, a NA study, has completed, sponsored by Lindenwood University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the changes in energy expenditure, fat oxidation, reaction time, and perceptual indicators of energy and focus after acute ingestion of a caffeine-based energy drink. Approximately 60 healthy adults aged 18-50 will be recruited for a randomized, double-blind, placebo-controlled study. They will undergo baseline measurements for energy expenditure, fat and carbohydrate oxidation, reaction time, cognition, and perceptual indicators of energy, focus, and concentration. After 28 days, these measurements will be taken again, comparing the effects of a caffeine-based energy drink versus a placebo.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Caffeine-Based Energy Drink

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-09-01
Est. Completion 2024-04-23
Phase NA

Sponsor

Lindenwood University

29 total trials

What the Registry Record Tells You About NCT05998096

The ClinicalTrials.gov registry entry for NCT05998096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05998096 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05998096 about?

NCT05998096 is a clinical study titled "A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators". The purpose of this study is to evaluate the changes in energy expenditure, fat oxidation, reaction time, and perceptual indicators of energy and focus after acute ingestion of a caffeine-based energy drink. Approximately 60 healthy adults aged 18-50 will be recruited for a randomized, double-blind,...

What is the current status of trial NCT05998096?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-09-01. Estimated completion is 2024-04-23.

What interventions are being tested in trial NCT05998096?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Caffeine-Based Energy Drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05998096?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.